姓名：扈曉芳

職稱：講師、主治醫(yī)師

專業(yè)：臨床醫(yī)學(xué)（內(nèi)科學(xué)）

教研室：內(nèi)科學(xué)教研室

電子郵箱：202101013@hunnu.edu.cn

通訊地址：湖南省長沙市岳麓區(qū)桐梓坡路371號

研究方向：腎臟疾病的基礎(chǔ)和臨床研究

簡介：扈曉芳，醫(yī)學(xué)博士，畢業(yè)于中南大學(xué)湘雅bwin必贏，2013年-2017年在湖南省人民醫(yī)院從事醫(yī)療工作。2021年在bwin必贏臨床醫(yī)學(xué)系從事教學(xué)工作。獲課堂教學(xué)競賽院級、校級二等獎。近年來參與國家自然科學(xué)基金項目2項，發(fā)表SCI論文十余篇。

近5年代表性學(xué)術(shù)論文（以第一作者^#或通訊作者^*已發(fā)表SCI論文）

1.Hu Xiaofang^#,Xie Yuhong, Xiao Yi et al. Longitudinal analysis of fecal microbiome and metabolome during renal fibrotic progression in a unilateral ureteral obstruction animal model.[J] .Eur J Pharmacol, 2020, 886: 173555.

2.Hu Xiaofang^#,Ouyang Shaxi, Xie Yuhong et al. Characterizing the gut microbiota in patients with chronic kidney disease.[J] .Postgrad Med, 2020, 132: 495-505.

3.Hu Xiaofang^#,Du Jie, Xie Yuhong et al. Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study.[J] .BMC Nephrol, 2020, 21: 97.

4.Hu Xiaofang^#,Yang Ming, Li Duan Jianxiuet al. Knowledge, attitude, and practice of nephrologists on the decision for renal replacement therapy.[J] .BMC Public Health, 2023, 23: 654.

5.Hu Xiaofang^#,Yang Ming, Li Xiangyi Myo-Inositol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy by Inhibiting PI3K/AKT Activation.[J] .J Med Food, 2023.

6. Hu Xiaofang^#,Liu Hengdao, Du Jie et al. The clinical significance of plasma CFHR 1-5 in lupus nephropathy.[J] .Immunobiology, 2019, 224: 339-346.

7.Hu Xiaofang^#,Liu Wanli,Yan Yuanliang et al. Vitamin D protects against diabetic nephropathy: Evidence-based effectiveness and mechanism.[J] .Eur J Pharmacol, 2019, 845: 91-98.

8.Chen, Ying,Hu Xiaofang*, et al. Retrospective analysis of crescent score in clinical prognosis of IgA nephropathy. Open Med (Wars). 2022; 17 (1): 205-215.